I agree, the rails already exist and are operationally more cost effective to leverage in any go to market strategy. No concern bringing in expertise who knows how to navigate these waters. I've invested in too many companies that have failed to commercialise product because they've underestimated how difficult it is to build a distribution funnel.
- Forums
- ASX - By Stock
- BOD
- Ann: Leading pharmaceutical executive to be appointed as Chairman
Ann: Leading pharmaceutical executive to be appointed as Chairman, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOD (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
BOD (ASX) Chart |
Day chart unavailable